| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 11.1 | 63.1 | 11.6 |
| Total income | 11.1 | 63.1 | 11.6 |
| Profit before exceptional items & tax | 1.5 | 2.2 | 1.4 |
| Profit before tax | 1.5 | 2.2 | 1.4 |
| Net profit | 1.1 | 1.7 | 0.7 |
| Operating margin | 13.5% | 3.5% | 12.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +57.10% |
|---|---|
| Net profit, quarter on quarter | -35.30% |
| Revenue, year on year | -4.30% |
NSE results filing, NSE: JFLLIFE. Figures extracted from the filing.
JFL Life Sciences Ltd: key numbers
- Share price
- ₹10.25
- Market cap
- ₹67.64 Cr
- Revenue (annual)
- ₹131.4 Cr
- Net profit (annual)
- ₹6.40 Cr
- P/E (TTM)
- 10.6×Sector 47.4×
- Promoter holding
- 67.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JFL Life Sciences Ltd
All →JFL Life Sciences Management Change
JFL Life Sciences Limited announced the re-appointment of its Managing Director, Whole-time Director, and two Independent Directors, each for a five-year term.
JFL Life Sciences Annual General Meeting
Jfl Life Sciences Limited held its 16th Annual General Meeting on August 25, 2026, via video conferencing to transact business as per the notice.
JFL Life Sciences Board Meeting Date
JFL Life Sciences Limited will hold a board meeting on 10-Aug-2026 to approve the company's unaudited standalone financial results for the quarter ended June 2026.
JFL Life Sciences Annual General Meeting
JFL Life Sciences Limited issued a notice for its 16th Annual General Meeting, scheduled for August 25, 2026, to consider financial and managerial appointments.
JFL Life Sciences Management Change
JFL Life Sciences Limited appointed Mr. Jignesh Sharma as Internal Auditor for FY 2026-27. The chartered accountant brings over a decade of bank auditing expertise.
- Execution
- 12 months (2026-2027)
JFL Life Sciences Q4 FY26 Results: Net Profit ₹1.7 Cr, Up 1600.0% YoY
JFL Life Sciences Ltd reported revenue from operations of ₹63.1 Cr (+439.3% YoY) and net profit of ₹1.7 Cr (+1600.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹1.7 Cr · +1600.0% YoY